Fito M, Guxens M, Corella D, Saez G, Estruch R, de la Torre R, Frances F, Cabezas C, Lopez-Sabater Mdel C, Marrugat J, Garcia-Arellano A, Aros F, Ruiz-Gutierrez V, Ros E, Salas-Salvado J, Fiol M, Sola R, Covas MI: Effect of a traditional Mediterranean diet on lipoprotein oxidation: a randomized controlled trial. Arch Intern Med 2007, 167: 1195-1203.
Article
Google Scholar
Mitrou PN, Kipnis V, Thiebaut AC, Reedy J, Subar AF, Wirfalt E, Flood A, Mouw T, Hollenbeck AR, Leitzmann MF, Schatzkin A: Mediterranean dietary pattern and prediction of all-cause mortality in a US population: results from the NIH-AARP Diet and Health Study. Arch Intern Med 2007, 167: 2461-2468.
Article
Google Scholar
O'Keefe JH, Bell DS: Postprandial hyperglycemia/hyperlipidemia (postprandial dysmetabolism) is a cardiovascular risk factor. Am J Cardiol 2007, 100: 899-904.
Article
Google Scholar
Eckel RH, Grundy SM, Zimmet PZ: The metabolic syndrome. Lancet 2005, 365: 1415-1428.
Article
CAS
Google Scholar
Moller DE, Kaufman KD: Metabolic syndrome: a clinical and molecular perspective. Annu Rev Med 2005, 56: 45-62.
Article
CAS
Google Scholar
Ford ES: Prevalence of the metabolic syndrome defined by the International Diabetes Federation among adults in the U.S. Diabetes Care 2005, 28: 2745-2749.
Article
Google Scholar
Batsis JA, Nieto-Martinez RE, Lopez-Jimenez F: Metabolic syndrome: from global epidemiology to individualized medicine. Clin Pharmacol Ther 2007, 82: 509-524.
Article
CAS
Google Scholar
Day C: Metabolic syndrome, or What you will: definitions and epidemiology. Diab Vasc Dis Res 2007, 4: 32-38.
Article
Google Scholar
Forsythe CE, Phinney SD, Fernandez ML, Quann EE, Wood RJ, Bibus DM, Kraemer WJ, Feinman RD, Volek JS: Comparison of low fat and low carbohydrate diets on circulating fatty acid composition and markers of inflammation. Lipids 2008, 43: 65-77.
Article
CAS
Google Scholar
Volek JS, Feinman RD: Carbohydrate restriction improves the features of Metabolic Syndrome. Metabolic Syndrome may be defined by the response to carbohydrate restriction. Nutr Metab (Lond) 2005, 2: 31.
Article
Google Scholar
Volek JS, Fernandez ML, Feinman RD, Phinney SD: Dietary carbohydrate restriction induces a unique metabolic state positively affecting atherogenic dyslipidemia, fatty acid partitioning, and metabolic syndrome. Prog Lipid Res 2008, 47: 307-318.
Article
CAS
Google Scholar
Riccardi G, Giacco R, Rivellese AA: Dietary fat, insulin sensitivity and the metabolic syndrome. Clin Nutr 2004, 23: 447-456.
Article
CAS
Google Scholar
Dandona P, Aljada A, Bandyopadhyay A: Inflammation: the link between insulin resistance, obesity and diabetes. Trends Immunol 2004, 25: 4-7.
Article
CAS
Google Scholar
McGarry JD: Banting lecture 2001: dysregulation of fatty acid metabolism in the etiology of type 2 diabetes. Diabetes 2002, 51: 7-18.
Article
CAS
Google Scholar
Slawik M, Vidal-Puig AJ: Lipotoxicity, overnutrition and energy metabolism in aging. Ageing Res Rev 2006, 5: 144-164.
Article
CAS
Google Scholar
Boden G, Chen X, Rosner J, Barton M: Effects of a 48-h fat infusion on insulin secretion and glucose utilization. Diabetes 1995, 44: 1239-1242.
Article
CAS
Google Scholar
Brechtel K, Dahl DB, Machann J, Bachmann OP, Wenzel I, Maier T, Claussen CD, Haring HU, Jacob S, Schick F: Fast elevation of the intramyocellular lipid content in the presence of circulating free fatty acids and hyperinsulinemia: a dynamic 1H-MRS study. Magn Reson Med 2001, 45: 179-183.
Article
CAS
Google Scholar
Kelley DE, Mintun MA, Watkins SC, Simoneau JA, Jadali F, Fredrickson A, Beattie J, Theriault R: The effect of non-insulin-dependent diabetes mellitus and obesity on glucose transport and phosphorylation in skeletal muscle. J Clin Invest 1996, 97: 2705-2713.
Article
CAS
Google Scholar
Roden M, Price TB, Perseghin G, Petersen KF, Rothman DL, Cline GW, Shulman GI: Mechanism of free fatty acid-induced insulin resistance in humans. J Clin Invest 1996, 97: 2859-2865.
Article
CAS
Google Scholar
Permana PA, Menge C, Reaven PD: Macrophage-secreted factors induce adipocyte inflammation and insulin resistance. Biochem Biophys Res Commun 2006, 341: 507-514.
Article
CAS
Google Scholar
Weisberg SP, McCann D, Desai M, Rosenbaum M, Leibel RL, Ferrante AW Jr: Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest 2003, 112: 1796-1808.
Article
CAS
Google Scholar
Patiag D, Gray S, Idris I, Donnelly R: Effects of tumour necrosis factor-alpha and inhibition of protein kinase C on glucose uptake in L6 myoblasts. Clin Sci (Lond) 2000, 99: 303-307.
Article
CAS
Google Scholar
Plomgaard P, Bouzakri K, Krogh-Madsen R, Mittendorfer B, Zierath JR, Pedersen BK: Tumor necrosis factor-alpha induces skeletal muscle insulin resistance in healthy human subjects via inhibition of Akt substrate 160 phosphorylation. Diabetes 2005, 54: 2939-2945.
Article
CAS
Google Scholar
Ranganathan S, Davidson MB: Effect of tumor necrosis factor-alpha on basal and insulin-stimulated glucose transport in cultured muscle and fat cells. Metabolism 1996, 45: 1089-1094.
Article
CAS
Google Scholar
Ebbeling CB, Leidig MM, Sinclair KB, Hangen JP, Ludwig DS: A reduced-glycemic load diet in the treatment of adolescent obesity. Arch Pediatr Adolesc Med 2003, 157: 773-779.
Article
Google Scholar
Ebbeling CB, Leidig MM, Sinclair KB, Seger-Shippee LG, Feldman HA, Ludwig DS: Effects of an ad libitum low-glycemic load diet on cardiovascular disease risk factors in obese young adults. Am J Clin Nutr 2005, 81: 976-982.
CAS
Google Scholar
Maki KC, Rains TM, Kaden VN, Raneri KR, Davidson MH: Effects of a reduced-glycemic-load diet on body weight, body composition, and cardiovascular disease risk markers in overweight and obese adults. Am J Clin Nutr 2007, 85: 724-734.
CAS
Google Scholar
Sloth B, Krog-Mikkelsen I, Flint A, Tetens I, Bjorck I, Vinoy S, Elmstahl H, Astrup A, Lang V, Raben A: No difference in body weight decrease between a low-glycemic-index and a high-glycemic-index diet but reduced LDL cholesterol after 10-wk ad libitum intake of the low-glycemic-index diet. Am J Clin Nutr 2004, 80: 337-347.
CAS
Google Scholar
Giugliano D, Esposito K: Mediterranean diet and metabolic diseases. Curr Opin Lipidol 2008, 19: 63-68.
CAS
Google Scholar
Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III) Jama 2001, 285: 2486-2497.
Article
Google Scholar
Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA, Gordon DJ, Krauss RM, Savage PJ, Smith SC Jr, Spertus JA, Costa F: Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation 2005, 112: 2735-2752.
Article
Google Scholar
Giugliano D, Ceriello A, Esposito K: Are there specific treatments for the metabolic syndrome? Am J Clin Nutr 2008, 87: 8-11.
CAS
Google Scholar
O'Keefe JH, Gheewala NM, O'Keefe JO: Dietary strategies for improving post-prandial glucose, lipids, inflammation, and cardiovascular health. J Am Coll Cardiol 2008, 51: 249-255.
Article
Google Scholar
Lassila M, Allen TJ, Cao Z, Thallas V, Jandeleit-Dahm KA, Candido R, Cooper ME: Imatinib attenuates diabetes-associated atherosclerosis. Arterioscler Thromb Vasc Biol 2004, 24: 935-942.
Article
CAS
Google Scholar
Lin JK: Molecular targets of curcumin. Adv Exp Med Biol 2007, 595: 227-243.
Article
Google Scholar
Si H, Liu D: Phytochemical genistein in the regulation of vascular function: new insights. Curr Med Chem 2007, 14: 2581-2589.
Article
CAS
Google Scholar
Lukaczer D, Liska DJ, Lerman RH, Darland G, Schiltz B, Tripp M, Bland JS: Effect of a low glycemic index diet with soy protein and phytosterols on CVD risk factors in postmenopausal women. Nutrition 2006, 22: 104-113.
Article
CAS
Google Scholar
Riccardi G, Clemente G, Giacco R: Glycemic index of local foods and diets: the Mediterranean experience. Nutr Rev 2003, 61: S56-60.
Article
Google Scholar
Foster-Powell K, Holt SH, Brand-Miller JC: International table of glycemic index and glycemic load values: 2002. Am J Clin Nutr 2002, 76: 5-56.
CAS
Google Scholar
Ware JE Jr, Sherbourne CD: The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care 1992, 30: 473-483.
Article
Google Scholar
White MA, Whisenhunt BL, Williamson DA, Greenway FL, Netemeyer RG: Development and validation of the food-craving inventory. Obes Res 2002, 10: 107-114.
Article
Google Scholar
Grundy SM, Pasternak R, Greenland P, Smith S Jr, Fuster V: AHA/ACC scientific statement: Assessment of cardiovascular risk by use of multiple-risk-factor assessment equations: a statement for healthcare professionals from the American Heart Association and the American College of Cardiology. J Am Coll Cardiol 1999, 34: 1348-1359.
Article
CAS
Google Scholar
Nauck M, Warnick GR, Rifai N: Methods for measurement of LDL-cholesterol: a critical assessment of direct measurement by homogeneous assays versus calculation. Clin Chem 2002, 48: 236-254.
CAS
Google Scholar
Maki KC, Galant R, Davidson MH: Non-high-density lipoprotein cholesterol: the forgotten therapeutic target. Am J Cardiol 2005, 96: 59K-64K.
Article
CAS
Google Scholar
Anderson RA: Chromium and polyphenols from cinnamon improve insulin sensitivity. Proc Nutr Soc 2008, 67: 48-53.
Article
CAS
Google Scholar
Heilbronn LK, Noakes M, Clifton PM: The effect of high- and low-glycemic index energy restricted diets on plasma lipid and glucose profiles in type 2 diabetic subjects with varying glycemic control. J Am Coll Nutr 2002, 21: 120-127.
Article
CAS
Google Scholar
Noakes M, Foster PR, Keogh JB, Clifton PM: Meal replacements are as effective as structured weight-loss diets for treating obesity in adults with features of metabolic syndrome. J Nutr 2004, 134: 1894-1899.
CAS
Google Scholar
De Keukeleire D: Fundamentals of beer and hop chemistry. Química Nova 2000, 23: 108-112.
Article
CAS
Google Scholar
De Keukeleire D, De Cooman L, Rong H, Heyerick A, Kalita J, Milligan SR: Functional properties of hop polyphenols. Basic Life Sci 1999, 66: 739-760.
CAS
Google Scholar
Abd el Nabi OM, Reisinger EC, Reinthaler FF, Still F, Eibel U, Krejs GJ: Antimicrobial activity of Acacia nilotica (L.) Willd. ex Del. var. nilotica (Mimosaceae). J Ethnopharmacol 1992, 37: 77-79.
Article
CAS
Google Scholar
Al-Mustafa ZH, Dafallah AA: A study on the toxicology of Acacia nilotica. Am J Chin Med 2000, 28: 123-129.
Article
CAS
Google Scholar
Kaur K, Arora S, Hawthorne ME, Kaur S, Kumar S, Mehta RG: A correlative study on antimutagenic and chemopreventive activity of Acacia auriculiformis A. Cunn. and Acacia nilotica (L.) Willd. Ex Del. Drug Chem Toxicol 2002, 25: 39-64.
Article
CAS
Google Scholar
TR N: A Biology of Acacias. Melbourne, Oxford University Press; 1984.
Google Scholar
Shimura M, Hasumi A, Minato T, Hosono M, Miura Y, Mizutani S, Kondo K, Oikawa S, Yoshida A: Isohumulones modulate blood lipid status through the activation of PPAR alpha. Biochim Biophys Acta 2005, 1736: 51-60.
CAS
Google Scholar
Yajima H, Ikeshima E, Shiraki M, Kanaya T, Fujiwara D, Odai H, Tsuboyama-Kasaoka N, Ezaki O, Oikawa S, Kondo K: Isohumulones, bitter acids derived from hops, activate both peroxisome proliferator-activated receptor alpha and gamma and reduce insulin resistance. J Biol Chem 2004, 279: 33456-33462.
Article
CAS
Google Scholar
Jenkins DJ, Wolever TM, Kalmusky J, Guidici S, Giordano C, Patten R, Wong GS, Bird JN, Hall M, Buckley G, et al.: Low-glycemic index diet in hyperlipidemia: use of traditional starchy foods. Am J Clin Nutr 1987, 46: 66-71.
CAS
Google Scholar
Esposito K, Marfella R, Ciotola M, Di Palo C, Giugliano F, Giugliano G, D'Armiento M, D'Andrea F, Giugliano D: Effect of a mediterranean-style diet on endothelial dysfunction and markers of vascular inflammation in the metabolic syndrome: a randomized trial. Jama 2004, 292: 1440-1446.
Article
CAS
Google Scholar
Orchard TJ, Temprosa M, Goldberg R, Haffner S, Ratner R, Marcovina S, Fowler S: The effect of metformin and intensive lifestyle intervention on the metabolic syndrome: the Diabetes Prevention Program randomized trial. Ann Intern Med 2005, 142: 611-619.
Article
CAS
Google Scholar
Ghandehari H, Kamal-Bahl S, Wong ND: Prevalence and extent of dyslipidemia and recommended lipid levels in US adults with and without cardiovascular comorbidities: the National Health and Nutrition Examination Survey 2003–2004. Am Heart J 2008, 156: 112-119.
Article
CAS
Google Scholar
Cui Y, Blumenthal RS, Flaws JA, Whiteman MK, Langenberg P, Bachorik PS, Bush TL: Non-high-density lipoprotein cholesterol level as a predictor of cardiovascular disease mortality. Arch Intern Med 2001, 161: 1413-1419.
Article
CAS
Google Scholar
Lu W, Resnick HE, Jablonski KA, Jones KL, Jain AK, Howard WJ, Robbins DC, Howard BV: Non-HDL cholesterol as a predictor of cardiovascular disease in type 2 diabetes: the strong heart study. Diabetes Care 2003, 26: 16-23.
Article
Google Scholar
Shai I, Rimm EB, Hankinson SE, Curhan G, Manson JE, Rifai N, Stampfer MJ, Ma J: Multivariate assessment of lipid parameters as predictors of coronary heart disease among postmenopausal women: potential implications for clinical guidelines. Circulation 2004, 110: 2824-2830.
Article
Google Scholar
Grundy SM, Cleeman JI, Merz CN, Brewer HB Jr, Clark LT, Hunninghake DB, Pasternak RC, Smith SC Jr, Stone NJ: Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines. Circulation 2004, 110: 227-239.
Article
Google Scholar
Chan DC, Watts GF: Apolipoproteins as markers and managers of coronary risk. Qjm 2006, 99: 277-287.
Article
CAS
Google Scholar
Hankey GJ: Potential new risk factors for ischemic stroke: what is their potential? Stroke 2006, 37: 2181-2188.
Article
Google Scholar
Hoffstedt J, Forster D, Lofgren P: Impaired subcutaneous adipocyte lipogenesis is associated with systemic insulin resistance and increased apolipoprotein B/AI ratio in men and women. J Intern Med 2007, 262: 131-139.
Article
CAS
Google Scholar
Ingelsson E, Schaefer EJ, Contois JH, McNamara JR, Sullivan L, Keyes MJ, Pencina MJ, Schoonmaker C, Wilson PW, D'Agostino RB, Vasan RS: Clinical utility of different lipid measures for prediction of coronary heart disease in men and women. Jama 2007, 298: 776-785.
Article
CAS
Google Scholar
Onat A, Can G, Hergenc G, Yazici M, Karabulut A, Albayrak S: Serum apolipoprotein B predicts dyslipidemia, metabolic syndrome and, in women, hypertension and diabetes, independent of markers of central obesity and inflammation. Int J Obes (Lond) 2007, 31: 1119-1125.
Article
CAS
Google Scholar
Rasouli M, Kiasari AM: Interactions of serum hsCRP with apoB, apoB/AI ratio and some components of metabolic syndrome amplify the predictive values for coronary artery disease. Clin Biochem 2006, 39: 971-977.
Article
CAS
Google Scholar
Sierra-Johnson J, Somers VK, Kuniyoshi FH, Garza CA, Isley WL, Gami AS, Lopez-Jimenez F: Comparison of apolipoprotein-B/apolipoprotein-AI in subjects with versus without the metabolic syndrome. Am J Cardiol 2006, 98: 1369-1373.
Article
CAS
Google Scholar
Walldius G, Jungner I: The apoB/apoA-I ratio: a strong, new risk factor for cardiovascular disease and a target for lipid-lowering therapy – a review of the evidence. J Intern Med 2006, 259: 493-519.
Article
CAS
Google Scholar
Yusuf S, Hawken S, Ounpuu S, Dans T, Avezum A, Lanas F, McQueen M, Budaj A, Pais P, Varigos J, Lisheng L: Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet 2004, 364: 937-952.
Article
Google Scholar